References
- Charfield, S., M. Roberts., P. London, I. Cropley, G. Douce, and G. Dougan. 1993. The development of oral vaccines based on live attenuated Salmonella strain. FEMS Immunol. Med. Microbiol. 7: 1-7 https://doi.org/10.1111/j.1574-695X.1993.tb00374.x
- Cookson, B. T. and M. J. Bevan. 1997. Identification of a natural T cell epitope presented by Salmonella infected macrophages and recognized by T cells from orally immunized mice. J. Immunol. 158: 4310-4319
- Ferreccio, C., M. M. Levine, H. Rodriguez, and R. Contreras. 1989. Comparative efficacy of two, three, or four doses of Ty21a live oral typhoid vaccine in enteric-coated capsule; a field trial in an endemic area Infect. Immun. 159: 766-769
- Foster, J. W. and B. Bearson. 1994. Acid-sensitive mutants of Salmonella typhimurium identification through a dinitrophenol lethal screening strategg. J. Bacteriol. 176: 2596-260 https://doi.org/10.1128/jb.176.9.2596-2602.1994
- Gill, H. S., D. L. Watson, and M. R. Brandon. 1992. In vivo inhibition by monoclonal antibody to CD4+ T cells of humoral and cellular immunity in sheep. Immunology 77: 38-42
- Hohmann, E. L., C. A. Oletta, K. P. Killeen, and S. I. Miller. 1996. phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J. Infect. Dis. 173: 1408-1414 https://doi.org/10.1093/infdis/173.6.1408
- Holly, E. A. and W. Foster. 1982. Bacteriophage P22 as a vector for Mu mutagenesis in Salmonella typhimurium: Isolation of nad-Iac and pnu-Iac gene fusion. J. Bacteriol. 152: 959-962
- Hone, D. M., C. O. Tacket, A. M. Harris, B. Kay, G. Losonsky, and M. M. Levine. 1992. Evaluation in volunteers of a candidate live oral attenuated S. typhi vector vaccine. J. Clin. Invest. 90: 412-420 https://doi.org/10.1172/JCI115876
- Ivanoff, B., M. M. Levine, and P. H. Lambert. 1994. Vaccination against typhoid fever: Present status. Bull. World Health Organ. 72: 957-971
- Jonson, V. J., M. Tsunoda, and R. P. Sharma. 2000. Increased production of proinflammatory cytokines by murine macrophage following oral exposure to sodium selenite but not to seleno-L-methionine. Arch. Environ. Contam. Toxicol. 39: 243-250 https://doi.org/10.1007/s002440010101
- Kim, S. H., O. Y. Lim, S. H. Kim, J. Y. Kim, Y. H. Kang, and B. K. Lee. 2003. Pulsed-field gel electrophoresis and mutation typing of gyrA gene of quinolone-resistant Salmonella enterica serovar paratyphi a isolated from outbreak and sporadic cases, 1998-2002, Korea. J. Microbiol. Biotechnol. 13: 155-158
- Lee, H. Y., J. H. Park, S. H. Seok, S. A. Cho, M. W. Baek, D. J. Kim, Y. H. Lee, and J. H. Park. 2004. Dietary intake of various lactic acid bacteria suppresses Type 2 helper T cell production in antigen-primed mice splenocyte. J. Microbiol. Biotechnol. 14: 167-170
- Levine, M. M., D. Herrington, J. R. Murphy, J. G. Morris, G. Losonsky, B. Tall, A. A. Lindberg, S. Svenson, S. Baqar, and M. F. Edwards. 1987. Safety, infectivity, immunogenicity and in vivo ability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccine in man. J. Clin. Invest. 79: 888-902 https://doi.org/10.1172/JCI112899
- Mosmann, T. R. and R. L. Coffman. 1989. Th1 and Th2 cells: Different patterns of Iymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145-173 https://doi.org/10.1146/annurev.iy.07.040189.001045
- Muotiala, A. and P. H. Makela. 1990. The role of lNF-r in murine Salmonella typhimurium infection. Microb. Pathog. 8: 135-141 https://doi.org/10.1016/0882-4010(90)90077-4
- Pang, T., M. M. Levine, B. Ivanoff, J. Wain, and B. B. Finlay. 1998. Typhoid fever - important issues still remain. Trends Microbiol. 6: 131-133 https://doi.org/10.1016/S0966-842X(98)01236-0
- Raupach, B. S. and H. Kaufmann. 2001. Bacterial virulence, proinflammatory cytokines and host immunity: How to choose the appropriate Salmonella vaccine strain? Microbes Infect. 3: 1261-1269 https://doi.org/10.1016/S1286-4579(01)01486-1
- Sebastiani, G., V. Blais, V. Sancho, S. N. Vogel, M. M. Stevenson, P. Gros, J. M. Lapointe, S. Rivest, and D. Malo. 2002. Host immune response to Salmonella enterica serovar typhimurium infection in mice derived from wild strains. Infect. Immun. 70: 1997-2009 https://doi.org/10.1128/IAI.70.4.1997-2009.2002
- Sirard, J. C., F. Niedergang, and J. P. Kraehenbuhl. 1999. Live attenuated Salmonella: A paradigm of mucosal vaccines. Immunol. Rev. 171: 5-26 https://doi.org/10.1111/j.1600-065X.1999.tb01340.x
- Staats, H. F., R. J. Jackson, M. Marinaro, I. Takahashi, H. Kiyono, and J. R. McGhee. 1994. Mucosal immunity to infection with implication for vaccine development. Curr. Opin. Immunol. 6: 572-583 https://doi.org/10.1016/0952-7915(94)90144-9
- Tacket, C. O., D. M. Hone, R. I. Curtiss, S. M. Kelly, O. Losonsky, L. Guers, A. M. Harris, R. Edelman, and M. M. Levine. 1992. Comparison of the safety and immunogenicity of aroCaroD and cya,crp Salmonella typhi strains in adult volunteers. Infect. Immun. 60: 536-541
- Tacket, C. O., M. B. Sztein, S. S. Wasserman, G. Losonsky, K. L. Kotloff, T. L. Wyant, J. P. Nataro, R. Edelman, J. Perry, P. Bedford, D. Brown, S. Chatfield, G. Dougan, and M. M. Levine. 2000. Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers. Infect. Immun. 68: 1196-1201 https://doi.org/10.1128/IAI.68.3.1196-1201.2000
- Thatte, J., S. Rath, and V. Bal. 1995. Analysis of immunization route-related variations in the immune response to heat-killed Salmonella typhimurium in mice. Infect. Immun. 63: 99-103
-
Wang, J. Y., M. F. Pasetti, F. R. Noriega, R. I. Anderson, S. S. Wasserman, J. E. Galen, M. B. Sztein, and M. M. Levine. 2001. Construction, genotyping and phenotyping characterization, and immunogenicity of attenuated
${\Delta}$ guaBA Salmonella enterica serovar typhi strain CDV 915. Infect. Immun. 69: 4734-4741 https://doi.org/10.1128/IAI.69.8.4734-4741.2001